Insights about U.S. Stocks from mix sectors that landed in the Green-Zone in the course of Tuesday’s trade, are depicted underneath:

ZIOPHARM Oncology Inc (NASDAQ:ZIOP)’s shares picked up 5.94%, and closed at $12.49, hitting new 52-week high of $12.60, during the last trading session.

ZIOPHARM Oncology, Inc. formerly on February 26, declared financial results for the fourth quarter and full year ended December 31, 2014, and offered an update on the corporation’s recent activities.

Fourth-Quarter 2014 Financial Results:

• Net loss for the fourth quarter of 2014 was $10.4 million, or $(0.09) per share, contrast to a net loss of $8.9 million, or $(0.09) per share, for the fourth quarter of 2013. Comprised of in the loss for the fourth quarter of 2014 was a non-cash gain of $194 thousand contrast to a non-cash loss of $1.8 million for the fourth quarter of 2013. The non-cash gain/loss is related to the change in the fair value of the Corporation’s outstanding liability-classified warrants.
• Research and development expenses were $8.1 million for the fourth quarter of 2014 contrast to $2.7 million for the fourth quarter of 2013. The raise of $5.4 million in research and development expenses is primarily attributable to our synthetic biology programs, which have recently expanded.
• General and administrative expenses were $2.9 million for the fourth quarter of 2014 contrast to $4.2 million for the fourth quarter of 2013.
• During the fourth quarter of 2014, the Corporation issued 1,755,845 shares of its ordinary stock upon the exercise of outstanding warrants resulting in aggregate proceeds to the Corporation of about $6.9 million.

ZIOPHARM Oncology, Inc., a biotechnology corporation, engages in the discovery and development of cancer therapies. The corporation is employing novel gene expression and control technology to deliver DNA for the treatment of cancer. Its technology platform employs Intrexon Corporation’s RheoSwitch Therapeutic System technology to turn on and off, and precisely modulate, gene expression at the cancer site in order to improve the therapeutic index.

Approach Resources Inc (NASDAQ:AREX), raised 5.91%, and closed at $8.07, hitting new 52-week high of $14.37.

Approach Resources, Inc. declared that the Corporation will take part in one-on-one investor meetings at the Simmons & Corporation International Fifteenth Annual Energy Conference on Thursday, March 5, 2015. Additionally, Approach’s Chairman, Chief Executive Officer and President J. Ross Craft will present at the Scotia Howard Weil 43rd Annual Energy Conference on Wednesday, March 25, 2015, at 9:15 AM CT.

Approach Resources Inc., an independent energy corporation, focuses on the exploration, development, production, and attainment of unconventional oil and gas reserves in the United States. The corporation’s properties are primarily located in the Permian Basin in west Texas. It also owns interests in east Texas Basin.

OHR Pharmaceutical Inc (NASDAQ:OHRP), enhanced 5.83%, and closed at $10.35.

Ohr Pharmaceutical, Inc. an ophthalmology research and development corporation, declared that Dr. Irach Taraporewala, Chief Executive Officer, will present a corporate overview and business update at the 35th Annual Cowen & Corporation Health Care Conference, on Wednesday, March 4, at 9:20am Eastern.

OHR Pharmaceutical, Inc., a pharmaceutical corporation, focuses on the development of novel therapeutics and delivery technologies for the treatment of ocular disease. Its lead clinical program is OHR-102 eye drops, a novel therapeutic product, which could provide a non-invasive therapy to improve vision outcomes. The corporation is evaluating OHR-102 eye drops in various Phase II studies for the treatment of retinal diseases, counting wet-AMD, retinal vein occlusion, proliferative diabetic retinopathy, and diabetic macular edema.

Sanchez Energy Corp (NYSE:SN), rose 5.77%, and closed at $13.01.

Sanchez Energy Corporation, declared the Corporation’s operating and financial results for the fourth quarter and full-year 2014, which comprised of the following highlights:

HIGHLIGHTS FOR FOURTH QUARTER 2014:

• Record proceeds of $172.5 million, an raise of 33% over the preceding year,
• Record production of 4,039 MBOE; an average of 43,897 BOE/D,
• Adjusted EBITDA, a non-GAAP financial measure defined below, of $133.7 million, an raise of 36% over the preceding year,
• Current production of about 44,000 BOE/D,
• Estimated proved reserves of about 135 MMBOE at December 31, 2014, up more than 7 MMBOE, or 6%, from about 127 MMBOE at September 30, 2014, and up over 76 MMBOE, or 129%, from about 59 MMBOE at December 31, 2013,
• First quarter and full year 2015 production guidance range re-affirmed at 40,000 to 44,000 BOE/D,
• Capital plan for 2015 re-affirmed at $600 - $650 million,
• Net loss attributable to ordinary stockholders of $66.1 million, which comprises a non-cash after tax impairment charge of $139.0 million due to the decline in commodity prices,
• Liquidity of $774 million as of December 31, 2014 comprising of $474 million in cash and cash equivalents and a $650 million unused accessible borrowing base with a $300 million elected commitment amount under our revolving credit facility.

Sanchez Energy Corporation, an independent exploration and production corporation, focuses on the attainment, exploration, and development of unconventional oil and natural gas resources in the onshore U.S. Gulf Coast. As of March 5, 2014, it had about 120,000 net leasehold acres in the oil and condensate, or black oil and volatile oil, windows of the Eagle Ford Shale in South Texas; about 57,000 net acres targeting the Tuscaloosa Marine Shale in Mississippi and Louisiana. The corporation was founded in 2011 and is based in Houston, Texas.